Sign in

CIK 0000899460

  • Large accelerated filer

MANNKIND CORP

Sign in to watch
Ticker
MNKD
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
133607736
Phone
+1 818-661-5000
Business address
1 CASPER STREET, DANBURY, CT, 06810
  1. 4 Grant or award Chief Financial Officer acquired 92,000 shares (grant or award)
  2. 4 Grant or award Chief People & Workpl Officer acquired 92,000 shares (grant or award)
  3. 4 Grant or award EVP Chief Medical Officer acquired 210,000 shares (grant or award)
  4. 4 Derivatives Options or other derivatives
  5. 4 Derivatives Options or other derivatives
  6. 4 Derivatives Options or other derivatives
  7. 4 Derivatives Options or other derivatives
  8. 4 Derivatives Options or other derivatives
  9. 3 Insider Initial Statement of Ownership
  10. 4 Open-market sale EVP Genl Counsel & Secretary sold 95,576 shares at $4.68 ($447,754)
  11. 4 Grant or award Chief People & Workpl Officer acquired 400,000 shares (grant or award)
  12. 4 Open-market sale Chief Executive Officer sold 150,000 shares at $4.69 ($702,780)
  13. 4 Open-market sale Chief Financial Officer sold 47,810 shares at $4.68 ($223,512)
  14. 4 Grant or award EVP Chief Operating Officer acquired 210,000 shares (grant or award)
  15. 4 Shares withheld for taxes EVP Genl Counsel & Secretary gave up 6,001 shares (to pay taxes)
  16. 4 Shares withheld for taxes Chief People & Workpl Officer gave up 5,941 shares (to pay taxes)
  17. 4 Shares withheld for taxes Chief Executive Officer gave up 16,434 shares (to pay taxes)
  18. 4 Shares withheld for taxes Chief Financial Officer gave up 5,972 shares (to pay taxes)
  19. 4 Grant or award EVP Chief Operating Officer acquired 14,184 shares (grant or award)
  20. 4 Grant or award Chief Financial Officer acquired 11,820 shares (grant or award)

Page 9 of 50 · 998 filings